CloseClose

 Encyclopedia.com -- Online dictionary and encyclopedia of facts, information, and biographies
Close window

AASLD: Once-Daily HCV Protease Inhibitors Show Early Promise

http://www.medpagetoday.com BOSTON -- Two investigational drugs targeting the hepatitis C virus (HCV) protease enzyme helped patients clear the virus with once-daily dosing, in contrast with the three-times-per-day schedule needed for similar drugs in development.

Close

For your enjoyment and convenience, YouTube videos are automatically associated with content at Encyclopedia.com. Because videos come directly from YouTube, we cannot endorse their accuracy, content, or quality. However, we hope you find them useful or entertaining while using Encyclopedia.com.

More YouTube videos About these videos

Close window